Systematic review of anticholinergic risk scales in older adults

European Journal of Clinical Pharmacology

Volumn 69, Issue 7, 2013, Pages 1485-1496

  Durán, Carlos E ^a   Azermai, Majda ^b   Stichele, Robert H Vander ^b  

^a UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Aged; Anticholinergic activity; Anticholinergic drugs; Risk scale

Indexed keywords

AMITRIPTYLINE; ATROPINE; BENZATROPINE; CHLORPHENIRAMINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; CLOZAPINE; CYPROHEPTADINE; DESIPRAMINE; DEXCHLORPHENIRAMINE; DICYCLOVERINE; DIPHENHYDRAMINE; DOXEPIN; FLUPHENAZINE; HYDROXYZINE; HYOSCYAMINE; IMIPRAMINE; LEVOMEPROMAZINE; MECLOZINE; NORTRIPTYLINE; ORPHENADRINE; OXYBUTYNIN; PROPANTHELINE BROMIDE; PROTRIPTYLINE; SCOPOLAMINE; THIORIDAZINE; TOLTERODINE; TRIHEXYPHENIDYL; UNINDEXED DRUG;

AGED; ANTICHOLINERGIC EFFECT; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG CLASSIFICATION; DRUG INFORMATION; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; ELDERLY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; RISK ASSESSMENT; SCREENING TEST; SYSTEMATIC REVIEW; VALIDATION PROCESS;

AGING; CHOLINERGIC ANTAGONISTS; DATABASES, PHARMACEUTICAL; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; POLYPHARMACY; RISK;

EID: 84879098801     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1499-3     Document Type: Review

References (20)

1. Tune LE (2001) Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 62(suppl 21):11-14
2. Hilmer SN, McLachlan A, Le Couteur DG (2007) Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 21:217-320
3. de Leon J (2011) Paying attention to pharmacokinetic and pharmacodynamic mechanisms to progress in the area of anticholinergic use in geriatric patients. Curr Drug Metab 12(7):635-646
4. Shi S, Klotz U (2011) Age-related changes in pharmacokinetics. Curr Drug Metab 12(7):601-610
5. Remillard AJ (1996) A pharmacoepidemiological evaluation of anticholinergic prescribing patterns in the elderly. Pharmacoepidemiol Drug Saf 5:155-164
6. Ness J, Hoth A, Barnett MJ, Shorr RI, Kaboli PJ (2006) Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 4(1):42-51
7. Kumpula E-K, Bell JS, Soini H, Pitkälä KH (2011) Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol 51(2):256-263
8. Gerretsen P, Pollock BG (2011) Rediscovering adverse anticholinergic effects. J Clin Psychiatry 72(6):869-870
9. Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ et al (2011) Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 59:875-880
10. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D et al (2011) Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 59:1477-1483
11. Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR (2006) The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 46:1481-1486
12. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332:455-459
13. Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Mahmoud RA et al (2008) Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 56(7):1333-1341
14. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168(5):508-513
15. Han L, Agostini JV, Allore HG (2008) Cumulative Anticholinergic exposure is associated with poor memory and executive funtion in older men. J Am Geriatr Soc 56:2203-2210
16. Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D (2010) Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry 81:160-165
17. Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S et al (2011) Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL Study. Dement Geriatr Cogn Disord 31:173-178
18. Sweetman SC (ed) (2011) Martindale: The complete drug reference. [online] Pharmaceutical Press, London < http://www.medicinescomplete.com/ > (Accessed on 11-2011).
19. Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I et al (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4:225-233
20. Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB (2013) Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A BiolSci Med Sci 68(3):271-278